KRAS and lung cancer: These data are consistent with another report that IDO deficiency mitigated lung tumor outgrowth, lesion formation, and MDSC suppressive function, improving overall survival in both KRAS-induced, spontaneous lung cancer and metastatic breast cancer models [6].